At a glance
ClinicalIndex Comparison RecordN/ACompleted· 44 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
microRNA Profile Associated With Positive Lymph Node Metastasis in Early-stage Cervical Cancer
In Brief
An observational study for Cervical Cancer. Completed, enrolled 44 participants.
Detailed Summary
Persistent infections with high-risk subtypes of the human papillomavirus (HPV) are recognized as the etiological factor for developing cervical cancer. The aim od this study was to identify a miRNA profile in patients with early-stage cervical cancer with positive lymph node metastasis treated. Formalin-fixed paraffin-embedded (FFPE) tissue samples of patients with a diagnosis of early-stage cervical cancer treated by radical hysterectomy with lymphadenectomy were collected.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Cancer
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2006
Primary CompletionSep 2013
First PostedSep 2019
TodayJul 2026
First PostedSep 12, 2019
Enrollment StartSep 1, 2006
Primary CompletionSep 30, 2013
TodayJul 2, 2026
Enrollment to primary: 7.1 yearsPosted 6.8 years ago